Product image of Mycosyst (Fluconazole) supplied by GNH India

Mycosyst

Active Ingredient:
Fluconazole
Origin:
EU

Mycosyst (Fluconazole)

Fluconazole, the active ingredient in Mycosyst, is a systemic antifungal presented as an oral dosage form for oral use. It treats a range of fungal infections, including candidiasis of the mouth, esophagus and vagina, cryptococcal meningitis, dermatophyte infections and other systemic mycoses.

GNH India supplies Mycosyst as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Fluconazole is used to treat fungal infections by targeting the Candida species and other pathogenic fungi.

  • Candidiasis (oropharyngeal, esophageal, vaginal): clears yeast overgrowth and relieves associated symptoms.
  • Cryptococcal meningitis: penetrates the central nervous system to eradicate Cryptococcus neoformans.
  • Dermatophyte infections: eliminates skin‑surface fungi causing ringworm and related conditions.
  • Systemic fungal infections: provides broad‑spectrum activity against invasive fungal pathogens.

How It Works

  • Fluconazole inhibits the fungal cytochrome P450 enzyme 14α‑demethylase, a key step in ergosterol synthesis. By blocking ergosterol production, the drug disrupts fungal cell membrane formation, leading to increased membrane permeability and ultimately fungal cell death. This mechanism provides selective activity against susceptible fungi while sparing human cells.

Side Effects

Fluconazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: transient cranial discomfort.
  • Diarrhea: loose stools occurring during therapy.
  • Abdominal pain: cramping or discomfort in the stomach area.
  • Rash: mild skin irritation or redness.

Serious or Rare Side Effects

  • Hepatotoxicity: elevated liver enzymes or liver injury.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • QT interval prolongation: potential cardiac rhythm disturbances.
  • Anaphylaxis: rare but life‑threatening allergic response.
  • Liver failure: acute hepatic dysfunction requiring medical attention.

Precautions & Warnings

Before initiating fluconazole therapy, consider the following precautions.

  • Assess liver function: evaluate baseline hepatic enzymes and monitor during treatment.
  • Review cardiac history: caution in patients with known QT prolongation or electrolyte imbalances.
  • Evaluate renal function: dosage adjustment may be needed in severe renal impairment.
  • Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited.
  • Drug interactions: check for concomitant medications that may affect fluconazole metabolism.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Avoid Interactions

Fluconazole interacts with several medicines; careful management is required.

Major Interactions (Avoid)

  • Warfarin: increased anticoagulant effect, risk of bleeding.
  • Simvastatin or lovastatin: elevated statin levels, risk of myopathy.
  • Cisapride: risk of serious cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: reduced efficacy, consider backup contraception.
  • Phenytoin or carbamazepine: decreased fluconazole levels, may reduce effectiveness.
  • Rifampin: induces metabolism, lowering fluconazole concentrations.
  • Ergot alkaloids: increased risk of ergotism, monitor for vasospasm.
  • Digoxin: possible increase in serum levels, monitor cardiac function.

Frequently Asked Questions

Mycosyst, containing fluconazole, is prescribed for infections caused by susceptible fungi such as oral, esophageal and vaginal candidiasis, cryptococcal meningitis, dermatophyte skin infections, and other systemic fungal diseases that require systemic antifungal therapy.

Fluconazole blocks the fungal enzyme 14α‑demethylase, preventing the synthesis of ergosterol, an essential component of fungal cell membranes. This disruption weakens the membrane, leading to fungal cell death while having minimal effect on human cells.

The specific dose of Mycosyst is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions precisely.

Safety data for fluconazole in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To request Mycosyst, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Fluconazole offers oral administration, good bioavailability, and a broad spectrum against many Candida species and Cryptococcus. Compared with azoles like itraconazole or voriconazole, fluconazole has fewer drug‑interaction concerns but may be less effective against resistant strains, making choice dependent on the pathogen and clinical scenario.

Mycosyst should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Mycosyst is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks include liver toxicity, severe skin reactions such as Stevens‑Johnson syndrome, QT interval prolongation leading to cardiac arrhythmias, and rare cases of anaphylaxis. Patients should report any signs of liver dysfunction, rash, or cardiac symptoms promptly.

Mycosyst is contraindicated in patients with known hypersensitivity to fluconazole or any azole antifungal. Caution is advised for individuals with significant liver disease, uncontrolled cardiac arrhythmias, or those taking medications that have major interactions with fluconazole.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.